Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SAR405
Cat. No.:
OB0225LY-0389
Appearance:
Liquid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
SAR405 is a selected autophagy inhibitor that affects the cellular autophagy process.
Synonym:
1523406-39-4; SAR-405; (S)-1-((5-Chloropyridin-3-yl)methyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one; (S)-9-((5-Chloropyridin-3-yl)methyl)-2-((R)-3-methylmorpholino)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one
CAS No.:
1523406-39-4
Compound CID:
72709209
Formula:
C19H21ClF3N5O2
Formula Weight:
443.85
Specification
Relative Density:
1.51 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SAR405 can be used in the study of cellular autophagy mechanisms or play an important role in the study of neurodegenerative diseases.
Library Information
Targets:
PI3K
Receptors:
Vps34
Pathways:
PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-6
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
27 mg/mL; 60.83 mM
